SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: w2004 who wrote (1574)6/23/2005 12:44:28 PM
From: Icebrg  Read Replies (1) | Respond to of 1826
 
I really don't know. I don't even know if estimates have caught up with the current situation - i.e. what appears to be a slowing of Aloxi sales. Or if the share price has caught up with revised estimates (if they have been revised).

More interesting, as far as I am concerned, is what will happen on September 1 - the PDUFA date for Dacogen. What comes out from FDA will IMHO define the rest of the year for MOGN.

Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News